AYTU BIOPHARMA INC (AYTU)
US0547548588 - Common Stock
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -18.00M | -17.05M | -110.17M | -58.29M | -13.62M | |||
| Depreciation Amortization | 8.72M | 8.82M | 10.25M | 9.20M | 6.25M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 1.72M | -5.80M | -10.86M | 1.68M | -12.61M | |||
| Interest Paid | 3.96M | 3.81M | 3.15M | 1.25M | 1.04M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 13.68M | 8.91M | 81.96M | 21.44M | -8.39M | |||
| OPERATING CASH FLOW | 6.11M | -5.13M | -28.82M | -25.96M | -28.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | -2.34M | 0.00 | |||
| Other Investing Activity | -410.00K | -120.00K | -3.25M | -440.00K | -5.66M | |||
| INVESTING CASH FLOW | -410.00K | -120.00K | -3.25M | -2.78M | -5.66M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.55M | -2.35M | -5.22M | -3.74M | -16.25M | |||
| Stock Issued/Repurchased | 4.10M | 15.58M | 11.69M | 45.05M | 92.72M | |||
| Other Financing Activity | -3.22M | -4.36M | -4.94M | -11.00M | -5.40M | |||
| FINANCING CASH FLOW | -5.68M | 8.87M | 1.53M | 30.31M | 71.07M | |||
| CHANGE IN CASH | 24.00K | 3.62M | -30.54M | 1.57M | 37.04M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 6.11M | -5.13M | -28.82M | -25.96M | -28.37M | |||
| Capital Expenditure | N/A | N/A | N/A | -2.34M | 0.00 | |||
| FREE CASH FLOW | 6.11M | -5.13M | -28.82M | -28.30M | -28.37M | |||
All data in USD